As shown in Table 1, clinical phenotype varied widely between metabolic groups, with a progressive increase in weight, body fat, glycated hemoglobin (HbA1c), glucose levels, and deteriorating insulin sensitivity and pancreatic beta cell function from the NG group to the T2D group (see Figures S1A–C). The gene discussed is INS; the disease is type 2 diabetes mellitus.